肝素酶(HPSE)多克隆抗體(生物素標(biāo)記)
Biotin-Linked Polyclonal Antibody to Heparanase (HPSE)
HPA; HPR1; HPSE1; HSE1; Endo-glucoronidase;
- 編號LAA711Mu71
- 物種Mus musculus (Mouse，小鼠)相同的名稱，不同的物種。
- 來源抗體標(biāo)記
- Ig類型IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物生物素
- 原抗體-
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC.
如果抗體需用于流式細胞術(shù)，請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價格¥ 641¥ 1495¥ 2136¥ 5340¥ 21360
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
Western Blot; Sample: Mouse Skin lysate
Primary Ab: 0.2μg/ml Biotin-Linked Polyclonal Antibody to Heparanase (HPSE)
Second Ab: 0.2μg/ml HRP-Labeled Streptavidin (Catalog: IS089)
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對HPSE的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別HPSE。
用法
免疫印跡：0.2-2μg/mL;1:250-2500
免疫組織化學(xué)：5-20μg/mL;1:25-100
免疫細胞化學(xué)：5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶決定。
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA711Mu02 | 肝素酶(HPSE)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA711Mu03 | 肝素酶(HPSE)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA711Mu04 | 肝素酶(HPSE)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA711Mu01 | 肝素酶(HPSE)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA711Mu01 | 肝素酶(HPSE)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA711Mu04 | 肝素酶(HPSE)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA711Mu03 | 肝素酶(HPSE)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA711Mu02 | 肝素酶(HPSE)多克隆抗體 | WB; IHC; ICC; IP. |
| FAA711Mu01 | 抗肝素酶(HPSE)多克隆抗體 | FCM |
| LAA711Mu71 | 肝素酶(HPSE)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| SEA711Mu | 肝素酶(HPSE)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA711Mu | 肝素酶(HPSE)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Plos one | PG545, a Heparan Sulfate Mimetic, Reduces Heparanase Expression In Vivo, Blocks Spontaneous Metastases and Enhances Overall Survival in the 4T1 Breast Carcinoma Model[Plosone: Source] |
| Journal of Medical Science | Assessment of heparanase and heparin-binding growth and angiogenesis factors in the uterine cavity ? uid in women with impaired reproduction[Nowinylekarskie:Source] |
| Int J Clin Exp Pathol | Unfractionated heparin attenuates intestinal injury in mouse model of sepsis by inhibiting heparanase[PubMed: 26191183] |
| Tumour Biology | PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection[PubMed: 26415733] |
| Journal of Medical Science | Assessment of heparanase and heparin-binding growth and angiogenesis factors in the uterine cavity fluid in women with impaired reproduction[article:84] |
| Renal Failure | Plasma heparanase is associated with blood glucose levels but not urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage [pubmed:28994624] |